Spectrum X Found and CEO Damien Hancox is joined by Aziz McMahon, Executive Chairman and Barry Saint, Chief Financial Officer to talk about the process for their late Spring IPO.
The healthcare and pharmaceutical company is tapping the potential of hypochlorous acid - recently firing the starting pistol on a £50mln listing by filing a prospectus with the London Stock Exchange.
SpectrumX will use the proceeds to commercially develop the potential of its patentable version of hypochlorous acid (HOCl), which has shown early signs of efficacy in COVID-19 and its mutations as well as other viruses.